CMT1067 - Non-Obstetric Ultrasound Services (NOUS)

Description

Non-Obstetric Ultrasound Service (NOUS) used to detect changes in the look, size or outline of tissues and vessels or to detect abnormal masses. This is a zero-based contract based on activity and national tariff. The contract expenditure for 2023/24 (12m and excluding the 6m Modification) was c.£500,000, to which a 6-month modification was added for £15k taking the lifetime contract value up to £625,000. This notice is for a Direct Award C PSR process to commence from the 08th of October 2024 for 12 months bringing the lifetime value of the contract to the value of c. £625,000. Under the test for considerable change this is within the permitted criteria (not exceeding £500,000 and 25%). Lot 1: Description of the services to be provided: Non-Obstetric Ultrasound Services (NOUS) used to detect changes in the look, size or outline of organs, tissues and vessels, or to detect abnormal masses. The ICB is intending to award a contract to an existing provider following direct award process C, where the existing provider is satisfying the existing contract and will likely satisfy the proposed new contract, and the contract is not changing considerably. The approximate lifetime value of the contract is £625,000 The dates between which the services are intended to be provided are: 08/10/2024 to 07/10/2025. Lot 1: Description of the services to be provided: Non-Obstetric Ultrasound Services (NOUS) used to detect changes in the look, size or outline of organs, tissues and vessels, or to detect abnormal masses. The ICB is intending to award a contract to an existing provider following direct award process C, where the existing provider is satisfying the existing contract and will likely satisfy the proposed new contract, and the contract is not changing considerably. The approximate lifetime value of the contract is £625,000 The dates between which the services are intended to be provided are: 08/10/2024 to 07/10/2025.